Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
Author:
Publisher
The Korean Association for the Study of the Liver
Subject
Molecular Biology,Hepatology
Link
http://e-cmh.org/upload/pdf/cmh-2016-0016.pdf
Reference21 articles.
1. Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2. Spectrum of portal vein thrombosis in the West
3. Consensus on extra-hepatic portal vein obstruction
4. Incidence of portal vein thrombosis in liver cirrhosis
5. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data;European Journal of Clinical Pharmacology;2024-03-02
2. Nonviral or Drug-Induced Etiologies of Acute-on-Chronic Liver Failure (Autoimmune, Vascular, and Malignant);Clinics in Liver Disease;2023-08
3. Portal Vein Variations, Clinical Correlation, and Embryological Explanation: A Review Article;Cureus;2023-03-20
4. Treatment of portal vein thrombosis in cirrhosis: a multicenter real life cοhort study;Minerva Gastroenterology;2023-02
5. Retrospective analysis of the efficacy and safety of rivaroxaban in the treatment of hepatic sinus obstruction syndrome caused by Gynura segetum;Community Acquired Infection;2022-03-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3